OverviewChartNewsTraderScreen

SOL-GEL TECHN. IS-,10/  IL0011417206  /

Frankfurt
2024-05-10  8:00:15 AM Chg. -0.0050 Volume Bid9:10:32 PM Ask9:32:41 PM High Low
0.6600EUR -0.75% 0
Turnover: 0.0000		 -Bid Size: - -Ask Size: - 0.6600 0.6600
GlobeNewswire 04-01 Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
GlobeNewswire 03-13 Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments
GlobeNewswire 2023-11-30 Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study
GlobeNewswire 2023-11-28 Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial...
GlobeNewswire 2023-11-09 Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire 2023-08-30 Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire 2022-03-25 Sol-Gel Technologies Announces U.S. Commercial Partner Galderma to Promote TWYNEO® at the American A...
GlobeNewswire 2021-12-22 Sol-Gel Technologies to Participate in Upcoming LifeSci Partners Corporate Access Event and H.C. Wai...
GlobeNewswire 2021-11-11 Sol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate De...
GlobeNewswire 2021-11-09 Sol-Gel Technologies to Present Live at Jefferies London Healthcare Conference
GlobeNewswire 2021-11-04 Sol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner Padagis for $21 Mill...
GlobeNewswire 2021-09-22 Sol-Gel Technologies to Present at Upcoming Cantor Virtual Global Healthcare Conference
GlobeNewswire 2021-09-09 Sol-Gel Technologies to Present at Upcoming H.C. Wainwright Global Investment Conference
GlobeNewswire 2021-08-04 Sol-Gel Technologies Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate D...
GlobeNewswire 2021-07-27 Sol-Gel Technologies Announces FDA Approval of TWYNEO®
GlobeNewswire 2021-07-20 Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on August 4th, 2021
GlobeNewswire 2021-06-28 Sol-Gel Announces Pipeline Update and Future Development Plans
GlobeNewswire 2021-05-27 Sol-Gel Technologies to Present at Upcoming Jefferies Healthcare Conference and Raymond James Human ...
GlobeNewswire 2021-05-13 Sol-Gel Technologies Reports First Quarter 2021 Financial Results and Corporate Update
GlobeNewswire 2021-04-27 Sol-Gel Technologies Provides Update on FDA Review of EPSOLAY®
GlobeNewswire 2021-03-04 Sol-Gel Technologies Reports Full Year 2020 Financial Results and Corporate Update
GlobeNewswire 2021-02-24 Sol-Gel Technologies to Present at Upcoming 2021 Raymond James Institutional Investors Conference an...
GlobeNewswire 2021-01-11 Sol-Gel Technologies to Present at Upcoming 2021 Solebury Trout Virtual Investor Conference and H.C....
GlobeNewswire 2020-12-07 Sol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Twyneo® for the...
GlobeNewswire 2020-11-12 Sol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corporate Update